Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/30/2004US20040265803 for the prevention, diagnosis and/or therapy of MSI+ tumors; antibodies against the gene product; use as antitumor agents or vaccines
12/30/2004US20040265367 Liposomes coated with selected antibodies that bind to aminophospholipids
12/30/2004US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
12/30/2004US20040265331 BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/30/2004US20040265330 Novel compounds
12/30/2004US20040265328 Identifying polypeptide antigens that bind to sera raised against commensal bacterial proteins
12/30/2004US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex
12/30/2004US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid
12/30/2004US20040265318 Use of antibodies for the vaccination against cancer
12/30/2004US20040265317 Methods and compositions useful for inhibition of angiogenesis
12/30/2004US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/30/2004US20040265315 Methods of preventing or treating T cell malignancies by administering CD2 antagonists
12/30/2004US20040265314 Soluble CLCA-1 and antagonists to CLCA-1
12/30/2004US20040265312 Anti-glutamic acid decarboxylase (anti-GAD) antibodies
12/30/2004US20040265308 Prevention and treatment of amyloidogenic disease
12/30/2004US20040265307 Anti-IGF-I receptor antibody
12/30/2004US20040265305 Inhibiting fibrosis, scleroderma, sarcoidosis, ankylosing spondilitis; monitoring the efficacy of the treatment; bioassay
12/30/2004US20040265304 Anti-CCR1 antibodies and methods of use therefor
12/30/2004US20040265303 Anti-CCR2 antibodies and methods of use therefor
12/30/2004US20040265301 Prevention and treatment of amyloidogenic disease
12/30/2004US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target
12/30/2004US20040265290 Lactic acid bacteria as agents for treating and preventing allergy
12/30/2004US20040265278 Moraxella catarrhalis antigen, corresponding gene and uses thereof
12/30/2004US20040265234 native and/or denatured food allergens recognized by IgE antibodies of food-allergy patients, antibodies prepared by immunizing an animal with the mixture and a method for detecting the food allergens and allergy-inducing foods that involves using said antibodies
12/30/2004US20040265229 Urokinase plasminogen activator receptor as a target for diagnosis of metastases
12/30/2004CA2469140A1 Hcv regulated proteins
12/29/2004WO2004113500A2 B7s1: an immune modulator
12/29/2004WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/29/2004WO2004113388A2 Anti alpha - folate - receptor - tetramer antibodies
12/29/2004WO2004113387A2 Tumour necrosis factor receptor molecules with reduced immunogenicity
12/29/2004WO2004113361A2 Novel prokineticin receptor isoforms and methods of use
12/29/2004WO2004112835A2 Suppression of transplant rejection
12/29/2004WO2004112834A1 Cancerous disease modifying antibodies
12/29/2004WO2004112829A2 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/29/2004WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004WO2004112565A2 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis
12/29/2004WO2004099418A8 Fused protein
12/29/2004WO2004096833A3 Inducers of recombinant protein expression
12/29/2004WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004WO2004090126A8 Phosphodiesterase 10a7 isoforms and methods of use
12/29/2004WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/29/2004WO2004083248A9 Antibodies to igf-i receptor for the treatment of cancers
12/29/2004WO2004078097A3 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer
12/29/2004WO2004065590A3 Activation and expansion of t cells
12/29/2004WO2004042009A3 Inhibition of il-17 production
12/29/2004WO2004013276A3 Novel tricistronic vectors and uses therefor
12/29/2004WO2003104429A3 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
12/29/2004WO2003068924A3 Fusion proteins of humanized g250 specific antibodies and uses thereof
12/29/2004WO2003057178A3 Viral capsid assembly intermediates
12/29/2004WO2003057146A3 Novel compositions and methods for cancer
12/29/2004WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004WO2003025200A3 Methods of using 22417, a novel human aminoprotease family member
12/29/2004WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004WO2000061774A3 Bone morphogenic proteins
12/29/2004EP1491890A1 Method of evaluating hair growth-promoting activity
12/29/2004EP1491889A2 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-beta peptide (x = 41) and tau
12/29/2004EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004EP1491209A1 Diagnostics and remedies for interstitial pneumonia
12/29/2004EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004EP1490407A1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
12/29/2004EP1490406A1 Costimulatory molecule and its use
12/29/2004EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004EP1490400A2 Tenascin-w compositions and uses thereof
12/29/2004EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004EP1490109A2 Egfr ligands and methods of use
12/29/2004EP1490107A1 Modulating angiogenesis
12/29/2004EP1490099A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
12/29/2004EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004EP1490082A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
12/29/2004EP1295606A4 Curing method for pathologic syndrome and a medicinal preparation
12/29/2004EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
12/29/2004EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004EP1147137A4 Methods for generating phosphorylation site-specific immunological reagents
12/29/2004EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004EP1090033B1 Particles of hcv envelope proteins: use for vaccination
12/29/2004EP0830130B9 Tnf-alpha converting enzyme
12/29/2004EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine
12/29/2004CN1558916A Compositions and methods for generating chimeric heteromultimers
12/29/2004CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation
12/29/2004CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004CN1557951A Method for preparing non-receptor type tyrosine protein kinase Syk and use thereof
12/29/2004CN1557838A SARS coronavirus nucleocapsid protein monoclonal antibody, hybridoma for producing the same, detection agent containing the same and use thereof
12/29/2004CN1557837A Process for preparing multi-bioactive substances from cattle colostrum
12/29/2004CN1557836A Preparation and use for immunosuppressive polypeptides